Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A Review of Mylan Laboratories Inc from 2000 to 2005 Covering Financial Information, Deals Made, and Its Subsidiaries with 48 Partnering Companies.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c26878) has announced the addition of Mylan Laboratories Inc Deals Briefing to their offering.

Description

Mylan Laboratories Inc Deals briefing provides an in-depth in-depth
adj.
Detailed; thorough: an in-depth study.


in-depth
Adjective

detailed or thorough: an in-depth analysis

 view of the 29 deals made by Mylan Laboratories Inc and its subsidiaries with 48 partnering companies between 2000 and 2005, in a clear and accessible PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format.  format.

Chapter 1: Company profile

An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

A detailed listing of all the company's deals and alliances announced between January January: see month.  2000 and July 2005.

Every deal is fully categorized cat·e·go·rize  
tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es
To put into a category or categories; classify.



cat
, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.

Scope

The report contains:

a brief company profile including subsidiary names

financial information where disclosed

a deals overview

specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 indexes including deals by partner company, subsidiary company, therapy focus and development stage

a detailed listing of the company's deals and alliances.

Key questions answered

Mylan Laboratories Inc Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:

identifying active partners

tracking competitor activity

benchmarking deals

comparing the finances of different deal types.

Mylan Laboratories Inc Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Mylan Laboratories Inc.

Forecasts, projections, market estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.

Who should buy the report

This report is essential reading for board and executive management, and individuals in:

business development

licensing/partnering

deal making

business strategy

marketing and promotion

distribution and manufacturing (including contract services).

Topics Covered

Introduction

About Partneringdesk Deals briefings

Chapter 1: Company profile

Chapter 2: Financial data and deals overview

Chapter 3: Summary of deals

Deals involving Mylan Laboratories Inc by partner company

Deals involving Mylan Laboratories Inc by subsidiary

Deals involving Mylan Laboratories Inc by therapy focus

Deals involving Mylan Laboratories Inc by development stage

Chapter 4: List of deals

Glossary A term used by Microsoft Word and adopted by other word processors for the list of shorthand, keyboard macros created by a particular user. See glossaries in this publication and The Computer Glossary.  

List of Tables

Table 2.1 Mylan Laboratories Inc financial summary

Table 2.2 Mylan Laboratories Inc deals by deal type

Table 2.3 Mylan Laboratories Inc deals by therapy focus

Table 2.4 Mylan Laboratories Inc deals by development stage

Table 2.5 Mylan Laboratories Inc deals by industry sector

Companies Mentioned

Bertek Pharmaceuticals

Jones Pharma Incorporated

King Pharmaceuticals King Pharmaceuticals (NYSE: KG), the world's 39th largest pharmaceutical company, is based in Bristol, Tennessee.[1][2] King produces a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a  Inc

Meridian Meridian (mərĭd`ēən), city (1990 pop. 41,036), seat of Lauderdale co., E Miss., near the Ala. line; settled 1831, inc. 1860.  Medical Technologies

Mylan Bertek Pharmaceuticals

UDL UDL Universal Design for Learning
UDL Universitat de Lleida (Spain)
UDL Universal Data Link
UDL Urban Debate League
UDL Uniformly Distributed Load (mechanics, building trade)
UDL User Defined Logic
 Laboratories

For more information visit http://www.researchandmarkets.com/reports/c26878
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 11, 2005
Words:525
Previous Article:TEC International Honors Bay Area Business Leader; John Walker of Los Altos Wins Don Cope Memorial Award.
Next Article:Nestle On Schedule to Meet Their Growth Targets for the Third Quarter of 2005.
Topics:



Related Articles
Mylan, VivoRx, Inc. and VivoRx Diabetes, Inc. Settle Litigation.
Mylan Receives Approval for Buspirone 15 mg.
Mylan Announces Senior Management Changes.
Mylan Statement Regarding Market Rumors.
Mylan Announces Conference Call Date for Third Quarter Fiscal 2004 Financial Results and Guidance for Fiscal 2005.
Mylan Reports Record EPS, Revenues and Net Earnings for the Third Quarter of Fiscal 2004; Mylan Announces Earnings Guidance for Fiscal 2005.
Mylan's New Patents Will Significantly Enhance Value of EMSAM.
An Overview Wyeth Deals Briefing, Including a Summary and List of 97 Deals and Financial Data.
An Analysis of Forest Laboratories Inc Including 13 Deals Made and 15 Partnering Companies from 2000 to 2005.
Review Major Developments at Generics Company Mylan.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles